SUMMARY The sensitivity of an indirect immunofluorescence antibody test (IFAT) and a rapid microagglutination test (RMAT) for the diagnosis of Legionnaires' disease caused by Legionella pneumophila serogroup 1 was evaluated using serum specimens from 119 patients with bacteriologically confirmed infections. The sensitivity of both assays was found to be about 80%. In addition, antibody titres suggestive of L pneumophila infection were found in 40% of patients in the first week after admission to hospital. These data show that both assays can be used with confidence in the early diagnosis of Legionnaires' disease.
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We have previously described two assays for the serodiagnosis of Legionnaires' disease caused by Legionella pneumophila serogroup 1. These are an indirect immunofluorescence antibody test (IFAT) using formolised yolk sac antigen prepared from the Pontiac strain of L pneumophila1 and a semiautomatable rapid microagglutination test (RMAT) using a formalin killed suspension of bacteria grown on solid media. 2 These assays are used routinely within the Public Health Laboratory Service and other clinical diagnostic laboratories in the United Kingdom, as well as in some similar laboratories in other European countries. Results have been published which show that these tests have good specificity and are reproducible,3 but to date the sensitivity of the assays has only been determined using sera from a small number of patients with bacteriologically confirmed Legionnaires' disease.
This study reports the results obtained by examining sera from a large series of patients in whom Legionnaires' disease had been bacteriologically confirmed. In addition to providing an accurate assessment of the sensitivity of each assay, it was intended that such a study would also show features of Legionnaires' disease which lead to problems in its serodiagnosis.
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PATIENTS
Patients were included in the series provided that they had a pneumonic illness clinically compatible with a diagnosis of Legionnaires' disease and that such a diagnosis was confirmed either by culture of L pneumophila serogroup 1 from clinical specimens or by showing the organism by immunofluorescence antibody staining, and that at least one serum specimen was available for the estimation of antibody titres.
Specimens were obtained from 119 patients who fulfilled these criteria-92 from the Hopital ClaudeBernard and 27 from the Central Public Health Laboratory (CPHL). The diagnosis had been established by culture in 103 cases, by fluorescence antibody demonstration of the organism in lower respiratory tract specimens in 15 cases, and by fluorescence antibody demonstration of the organism in sputum in one case (table 1) . Where possible, the following informa- (table 5) .
Specimens from 16 of the 119 patients gave negative results in one or both assays. Three were positive (two diagnostic) by IFAT and negative by RMAT, while one was diagnostic by RMAT and negative by IFAT. Ten cases were negative in both assays and two were IFAT negative and not tested in the RMAT.
Thus of the 115 patients tested in both assays, the RMAT and IFAT showed concordance in 111 (96-5%) cases.
TIMING OF THE ANTIBODY RESPONSE
The dates of both onset of illness and collection of the first serum specimen were known for 100 patients, and the average interval of time between these was 7-3 days (range one to 28). Similarly, the average time between admission and collection of the first serum A possible explanation for the difference in outcome might be that the only specimens available from the patients who died were collected soon after onset of Legionnaires' disease, before antibody was present at detectable titres. To determine whether this was the case the following analyses were performed: 1 The timing of death in relation to onset of illness was compared for seronegative and seropositive patients. The mean number of days between onset and death was 12-7 days (range four to 30, n = 8) for 80 IFAT seronegative patients and 15 5 days (range five to 31, n = 19) for IFAT seropositive patients. 2 The number of days between onset and the collection of last available specimen from IFAT seronegative patients who died was compared with the time from onset to the collection of the first serum specimen to give a positive result from IFAT seropositive patients who died. The mean for seronegative patients was 10-2 days (range four to 20, n = 9) and was 11 5 days (range four to 35, n = 30) for seropositive patients. 3 The number of days between onset and the last available serum specimen (taken within a month of onset) from seronegative patients (irrespective of the outcome of illness) was compared with the time from onset to the collection of the first serum specimen to give a positive IFAT result from seropositive patients (irrespective of the outcome of illness). The mean intervals were 9-6 days (range three to 20, n = 11) and 12-0 days (range three to 35, n = 89), respectively.
None of the differences observed between the groups approached significance, but as some of the groups contained only a few patients it is hard to draw any conclusions from these results.
Discussion
If a serological assay is to provide results helpful in the diagnosis of a patients's illness it must be rigourously evaluated. Variables such as the test sensitivity and specificity must be determined and from these the predictive values calculated. 5 The most important test variable in the case of an illness of low prevalence, such as Legionnaires' disease, is the specificity. This has been determined previously for both the IFAT and the RMAT, as used in this study, with regard to infections caused by Lpneumophila serogroup 1.3 It was shown that the specificity was excellent for both assays being 100% for a diagnostic result in the IFAT and 99 6% for the RMAT. In addition, it was shown that both the IFAT and RMAT were highly specific (about 97%) even with respect to positive, but not necessarily diagnostic, results.
The high specificity of these two assays indicates that considerable confidence can be placed in the validity of the diagnosis where specimens from a patient give serodiagnostic results. Unless the sensitivity has been determined, however, the percentage of patients who have Legionnaires' disease but fail to give serodiagnostic results will be unknown.
Although many serological assays have been described for the diagnosis of Legionnaires' disease, few have been adequately evaluated. Where attempts have been made to determine the sensitivity, these In the study presented here the estimate of the sensitivity of the IFAT and RMAT were determined using sera from 119 patients in whom Legionnaires' disease was diagnosed either by culture or demonstration of the organism in patients' specimens, or both of these methods. The results show that the IFAT has a sensitivity of 79-0% and the RMAT 817% with respect to a diagnostic result. From these results the predictive value of a diagnostic result in the RMAT is calculated to be between 67 and 91%, assuming the prevalence of Legionnaires' disease caused by L pneumophila serogroup 1 is 1-5% of patients with pneumonia. As the specificity of the IFAT is calculated as 100% the predictive value of a positive result is also 100%, irrespective of the sensitivity.5
In the case of both assays, although specimens from about 20% of the patients failed to give diagnostic results, positive titres were shown in about half (10% of the total) of these. While these results are not conclusive, they can be good indicators of a case of Legionnaires' disease (table 5) . Where a combination of both the IFAT and RMAT were used, the sensitivity of a diagnostic result rose from 79% and 8l17%, respectively, to 86-9%. This increase is accounted for largely by a decrease in the percentage of positive (but not diagnostic) results. The reliability of a diagnosis based on such positive results is affected by the prevalence of Legionnaires' disease in the population being examined. If the prevalence of Legionnaires' disease is 1-5% the predictive value of any positive IFAT or RMAT result is 23-60%.
The concordance seen between the IFAT and RMAT was very high (96-5%), but discrepant results were seen in four instances. In one of these (case 1, table 6) one specimen was taken five days after onset of symptoms. This specimen had an IFAT titre of 128 but was negative in the RMAT. Subsequent analysis showed the specific antibody to be only of the IgG immunogobulin class. This probably accounts for the discrepant results-being an agglutination assay, the RMAT is inefficient at detecting this class of antibody.8
Of particular interest are the specimens from case 4 (table 6). A diagnostic rise between the first specimen (three days after onset) and the second specimen (10 days) was shown by RMAT. These sera were negative by IFAT, and a third specimen (218 days) was negative in both assays. It is possible that had an appropriately timed third specimen been available a seroconversion would have been shown by IFAT, but this result does indicate that a RMAT diagnostic IFAT negative result is not necessarily a false positive result, as had been assumed previously. 2 Specimens from 10 patients were negative in both assays. Attempts were made to determine any features which distinguished this group from the other patients. The seronegative patients did not differ significantly in age, sex, and in whether they were immunocompromised or not from the remaining patients. It was found, however, that patients who died were more likely to have been seronegative than patients who survived. One possible explanation for this observation could be that appropriately timed serum specimens were not available from some of the patients with a fatal outcome. Although analysis of the data presented here does not support this explanation, it should not be discounted as the numbers of patients in the seronegative group were small and hence only major differences in the timing of serum specimens would have been detected.
It can be seen from the epidemiological data that the series of patients selected was a biased sample from the general population of patients with Legionnaires' disease. Although the age range and male: female ratios were typical,9 the mortality was considerably higher than usual.9 Over 50% of the patients were also immunocompromised. This, together with the fact that 67% (of those reported) required mechanical ventilation, suggests that the patients in this population were more severely ill than is typical in Legionnaires' disease. This is not surprising as it is probable that a severely ill patient will be investigated with greater rapidity and more intensively than those with milder disease, and hence L pneumophila will be isolated more often.
As discussed above, patients who died were more often seronegative than those who survived. As the percentage 'mortality in this series of patients exceeded that which would usually be expected, it may be that the percentage of seronegative patients was also excessive. Thus the sensitivities calculated here may be underestimates of the true values.
This study was not undertaken to investigate the timing of the antibody response in legionella infections, but the data presented illustrate an important point. In both assays about a third of the specimens taken from patients within 48 hours of admission to hospital were positive, and within a week of admission this figure had risen to over 40%. This clearly shows that when appropriate specimens are taken an early indication of a legionella infection can be obtained.
Conflicting results have been reported on the value of serology, especially in patient management in cases of Legionnaires' disease. There are two main explanations for this. Firstly, different techniques and antigen preparations have been used. Secondly, serological criteria established for the diagnosis of Legionnaires' disease caused by L pneumophila serogroup I have been extended to the many other serogroups and epecies now known, without any real assessment of 'he specificity or sensitivity of the serological tests using these different antigens.
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Harrison, Dournon, Taylor molised yolk sac antigen and the RMAT are highly specific. We have now shown that these tests have a similar sensitivity of about 80%, even in very severe cases and in immunocompromised patients. Overall, the sensitivity and specificity of these assays are such that they can be used with confidence in the early diagnosis of Legionnaires' disease. In our hands about 40% of patients with Legionnaires' disease confirmed by culture caused by L pneumophila serogroup 1 do have antibodies likely to indicate such an infection during the first week after admission to hospital.
